A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
The primary specific aim of this clinical trial is to determine whether treatment with
rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in
patients with Alzheimer's disease (AD) as measured by ADAScog.